Who has invested in Ionetix?

Eli Lilly, POINT Biopharma Global are named among the investors backing Ionetix.

Ionetix Funding: $85M Raised, Series F (2024)

Ionetix funding overview

Ionetix is based in Lansing, Michigan. Ionetix has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series F announced in August 2024. The round record for Ionetix runs through 2024; nothing later has been disclosed. Investors on record include Eli Lilly, POINT Biopharma Global. 2 distinct backers are named across the disclosed rounds.

Ionetix at a glance

Total raised: $85M
Latest round: Series F
Latest round date: August 2024
Headquarters: Lansing, Michigan
Notable investors: Eli Lilly, POINT Biopharma Global

Frequently asked about Ionetix funding

How much has Ionetix raised?: Ionetix has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Ionetix?: Eli Lilly, POINT Biopharma Global are named among the investors backing Ionetix.
What was the latest Ionetix funding round?: The most recent disclosed round is a Series F, announced in August 2024.
Where is Ionetix based?: Ionetix is based in Lansing, Michigan.
When did Ionetix last raise?: The last disclosed Ionetix round closed in August 2024 at Series F.

Ionetix totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Lansing below to benchmark round size and investor mix.

Ionetix Funding: $85M Raised, Series F (2024)

Ionetix funding overview

Ionetix at a glance

Frequently asked about Ionetix funding

Companies related to Ionetix (13)

Browse related funding lists (4)